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a  b  s  t  r  a  c  t
Asymmetric  Flow  Field-Flow  Fractionation  (AF4)  combined  with  multidetector  analysis  form  a  promising
technique  in  the ﬁeld  of  nanoparticle  characterization.  This  system  is  able  to measure  the  dimensions  and
physicochemical  properties  of  nanoparticles  with  unprecedented  accuracy  and  precision.  Here,  for  the
ﬁrst time,  this  technique  is  optimized  to characterize  the  interaction  between  an  archetypal  antimicrobial
peptide  and  synthetic  membranes.  By using  charged  and  neutral  liposomes  it  is  possible  to  mimic  some
of the charge  characteristics  of biological  membranes.  The  use  of AF4  system  allows  determining,  in  a
single  analysis,  information  regarding  the selectivity  of the  peptides,  the  quantity  of peptides  bound  to
each liposome,  the induced  change  in  the  size  distribution  and  morphology  of  the  liposomes.  The  resultshape factor
iposomes
ntimicrobial peptides
obtained  provide  relevant  information  for the study  of structure–activity  relationships  in  the  context  of
membrane-induced  antimicrobial  action.  This  information  will  contribute  to the  rational  design  of  potent
antimicrobial  agents  in the  future.  Moreover,  the  application  of  this  method  to other  liposome  systems
is straightforward  and would  be  extremely  useful  for a comprehensive  characterization  with  regard  to
size  distribution  and  protein  interaction  in  the  nanomedicine  ﬁeld.
© 2015  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Introduction
The size and morphology of nanosized objects is fundamentally
inked to their properties. The need for a comprehensive size char-
cterization of particles is critical in the ﬁeld of nanomedicine. The
ack of well-established, robust methods for measuring size and
hysicochemical properties of nanoparticles is hampering further
pplication of nanotechnology in medicine.
Liposomes have a widespread use in nanomedicine [1] due to
heir bilayer construction mimicking biological membranes [2] and
or their use as carriers for therapeutic agents [3,4]. In fact, several
f the approved nanodrugs currently on the market are liposome-
ased drug delivery systems [5].
Among all the techniques used to characterize particles, AF4 is
erhaps the most promising due to its ﬂexibility to separate accord-
ng to size a wide range of diverse particles [6]. The size-separated
anoparticles can then be directly analyzed by different detectors,
hus giving access to a large variety of characterization possibili-
ies. The combination of FFF with online multi angle light scattering
∗ Corresponding author. Tel.: +39 0332 786561; fax: +39 0332 789171.
E-mail address: luigi.calzolai@jrc.ec.europa.eu (L. Calzolai).
ttp://dx.doi.org/10.1016/j.chroma.2015.10.029
021-9673/© 2015 The Authors. Published by Elsevier B.V. This is an open access article unlicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
(MALS) and dynamic light scattering (DLS) creates a powerful sys-
tem for measuring the accurate particle size distribution in complex
heterogeneous and polydispersed mixtures [7].
This technique is increasingly used on a routine basis in a vari-
ety of ﬁelds, including food, pharmaceuticals, water treatment, and
chemical production [8–10]. In the ﬁeld of nanomedicine AF4 helps
to analyze small changes in size distribution or drug loading efﬁ-
ciency which are important aspects of quality control and essential
for regulatory affairs and medical approval. AF4 has only a medium
peak resolution, for example it can separate a mixture of silver
nanoparticles of 40 and 70 nm in size [11], but it would have prob-
lems in separating particles with closer sizes.
In this study, AF4 is used to characterize liposomes and their
interactions with antimicrobial peptides. Antimicrobial peptides
are an important part of the innate immunity system to ﬁght infec-
tion [12]. More than 1000 antimicrobial peptides (AMPs) have been
discovered in various organisms including humans [13] and as
the spread of antimicrobial resistance is no longer a future threat
[14], there is a pressing need to develop novel classes of antimi-
crobial agents. AMPs are recognized as promising candidates in
this regard [15]. The binding of AMPs to microbial membranes
is facilitated by electrostatic interactions with bacterial mem-
brane, rich in acidic phospholipids, which allows the hydrophobic
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ortions of the peptides to incorporate into the hydrophobic bilayer
nterfaces [16]. Electrostatic interactions can be viewed as a recog-
ition or selectivity means since mammalian cell membranes
re composed predominantly of zwitterionic phosphatidylcholine
PC) and sphingomyelin phospholipids [17]. These binding events
eﬁne the mechanism of action of AMPs. To understand these
echanisms in sufﬁcient detail model membranes that can mit-
gate the complexity of biological membranes while mimicking
heir physicochemical characteristics are necessary. Here we  used
iposomal unilamellar vesicles as model systems for elucidating
eptide–membrane interactions relevant to antimicrobial activity.
wo types of liposomes were used, anionic and neutral, to mimic
icrobial and mammalian membrane lipids, respectively. The lipo-
omes give straightforward ﬂuid-phase membranes at room and
hysiological temperature thus presenting ideal models for probing
elevant peptide–membrane interactions [18].
In this paper, we show that by means of AF4 hyphenated
o MALS, DLS, UV and Fluorescence spectroscopy detectors, it is
ossible to analyze particle size distribution and essential physi-
ochemical properties pertaining to the membrane interactions of
ntimicrobial peptides in unprecedented detail.
. Materials and methods
.1. Materials
Lipids dilaurylphosphatidylcholine (DLPC), dilaurylphos-
hatidylglycerol (DLPG), palmitoyloleoylphosphatidylcholine
POPC) and palmitoyloleoylphosphatidylglycerol (POPG) were
urchased from Avanti® Polar Lipids, Inc.
Salts used for the preparation of the mobile phase (monosodium
hosphate monohydrate and disodium phosphate dihydrate) were
urchased from Sigma–Aldrich.
The water used in this work was ultrapure water (prepared by
illi-Q®, Millipore S.A.) and was ﬁltered through a membrane ﬁlter
ith a pore size 0.22 m prior to use.
.2. Preparation of membrane models (liposomes)
Unilamellar vesicles consisting of POPC and POPC/POPG (3:1
ole ratio) were prepared by dissolving the lipids in a chloro-
orm:methanol (2:1, v:v) mixture at a concentration of 10 mg/mL.
he solution was then evaporated under nitrogen ﬂow overnight.
he dried ﬁlm was then resuspended in 10 mL of a 10 mM phos-
hate buffer, pH 7.4. The preparation was alternatively vortexed
or 2 min  and sonicated at room temperature for 2 min. The cycle
as repeated three times. The dispersion was extruded 21 times
hrough a 100-nm polycarbonate membrane before each use.
Vesicles consisting of DLPC and DLPC/DPLG (3:1 mole ratio)
ere prepared following the same procedure as described above.
.3. Peptide synthesis
All peptides were assembled on a Liberty microwave peptide
ynthesizer (CEM Corp) using Rink Amide MBHA resin, standard
olid-phase Fmoc/tBu protocols and HBTU/DIPEA as coupling
eagents. An additional -Ala residue was introduced at the N-
ermini of AmP  and nAmP to act as a spacer prior ﬂuorescein
abelling. Fluorescein coupling was performed on solid phase using
(6)-carboxyﬂuorescein, HBTU/DIPEA in a fourfold excess fashion
ver the total amount of peptide. Following cleavage and deprotec-
ion (95% TFA, 2.5% TIS, 2.5% water) peptides were puriﬁed using
P-HPLC and their purities were conﬁrmed by analytical RP-HPLC
nd MALDI-ToF. The purity of all peptides was higher than 95%.
oth analytical and semi-preparative RP-HPLC were performed
sing a JASCO HPLC system equipped with Vydac C18 columns A 1422 (2015) 260–269 261
(respectively 5 m,  4.6 mm × 250 mm for the analytical and 5 m,
10 mm  × 250 mm for the semi preparative). Both analytical and
semi preparative were run using a 10–60% B gradient over 46 min
at 1 mL/min and 4.7 mL/min respectively with detection at 214 and
280 nm.  Buffer A 5% and buffer B 95% acetonitrile in water with 0.1%
TFA.
MS [M+H]+: AmP  m/z 2534.64 (calc.), 2535.58 (observed);
nAmP m/z 2371.20 (calc.), 2370.95 (observed); F-AmP m/z 2963.68
(calc.), 2964.07 (observed); F-nAmP m/z 2800.24 (calc.), 2801.73
(observed);
2.4. Preparation of lipid to peptide (L/P) mole ratios
Amp  and nAmP peptide solutions at 0.5 mM were prepared
fresh before each experiment in 10 mM phosphate buffer, pH 7.4.
The concentration was calculated by reading UV–vis absorbance at
280 nm due to the presence of a single aromatic residue (Y) in both
peptides. For all experiments the lipid concentration of liposomes
was kept constant at 1.2 mM for all liposome–peptide complexes
studied. For a desired L/P ratio (mole), a 250 L peptide aliquot at a
deﬁned concentration (from 120 M to 16 M)  was added imme-
diately before the measurements to 750 L of a 1.6 mM liposome
solution. The ﬁnal volume of each sample solution was 1 mL.
2.5. Dynamic light scattering and Z potential analysis
The particle size distribution and the Z-potential were measured
using a Malvern Zetasizer Nano-ZS instrument. Each sample had a
volume of 500 L in a PMMA  cuvette and each measurement was
done at 25 ◦C in triplicate. The refractive index of liposomes used
was 1.45, the absorption coefﬁcient was  0.001.
The number of data sets of each measurement was automatically
optimized by the instrument according to the quality of the sam-
ple and the intensity of the scattered light (ideally the correlogram
should have amplitude around 0.8). The data was  analyzed using
the manufacturer’s Dispersion Technology Software (DTS version
7.01), using both the cumulant (single exponential) and multi-
modal analysis (multi exponential-Malvern, DTS algorithm). From
the cumulant analysis, the value of hydrodynamic diameter (Zave
(d.nm)) and polydispersity index (PdI) could be obtained. If the PdI
was greater than 0.5, the hydrodynamic radius was calculated from
the multimodal analysis. The instrument calibration was  checked
by using varied sizes of Polystyrene latex (PSL) beads standards.
Zetasizer ﬂow mode measurements were performed in a Hellma
Quartz Suprasil 3 mm ﬂow-through cuvette adjusted to 3.90 mm
measurement position and attenuator of 11. The temperature was
adjusted at 25 ◦C.
For both ﬂow and batch mode measurements were performed
at the 173◦ backscattering angle.
2.6. Analytical set up of Asymmetric Flow Field-Flow
Fractionation (AF4) system
Characterization of peptide–liposome complexes was carried
out using an AF4 system (AF2000 Postnova Analytics, Germany).
The channel used was 29 cm long with a spacer of 350 m,  a regen-
erated cellulose membrane with a 10 kDa cutoff was  used. The
ﬂows were provided by two  separate pumps and the cross-ﬂow
was realized by a separate piston pump which is continuously
adjustable. The eluent was phosphate buffer solution 10 mM,  pH
7.4 and was degassed by sonication with a water bath sonicator
and with a vacuum degasser just before delivery. The ﬂow was  kept
at 0.5 mL/min. Optimal separation of the liposomes was achieved
using an injection ﬂow of 0.20 mL/min and a constant cross-ﬂow of
degassed buffer solution of 1 mL/min for the ﬁrst 5 min. A power
gradient 1–0.1 mL/min for the next 60 min  was applied and then a
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onstant 0.1 mL/min for the next 10 min. The output from the
hannel was connected online to a 18-angle static light scattering
etector MALS (Dawn EOS, Wyatt Technology, Santa Barbara, CA,
SA), to a UV–vis spectrometer (SPD-2a AV, Postnova Analytics)
et at 500 nm wavelength for detection of the ﬂuorescein labeled
eptide, to a ﬂuorimeter (RF-20A XS) set at 500 nm excitation wave-
ength and 522 nm emission wavelength for the detection of the
uorescein labeled peptide and to a DLS (Zetasizer Nanos S, Malvern
nstruments Ltd.) for size determination. The injection volume was
0 L.
Data acquisition was carried out by AF200 control software ver-
ion 1.1.1.26 (Postnova Analytics) and Zetasizer software v 6.01
Malvern Instruments Ltd).
MALS data acquisition and procession was performed using
stra 6.1.1.17 (Wyatt Technology). The geometric radii (RG) of the
iposomes were calculated using the data from 18 angles from
he MALS detector applying the coated sphere model [19]. For the
oated sphere model, the coat thickness, refractive index of the coat
nd refractive index of the medium need to be speciﬁed. Coat thick-
ess was speciﬁed with 3.7 nm [20], the refractive index of the coat
as 1.45[21], the refractive index of the medium was  1.333.
Coated sphere model was chosen among other ﬁtting methods
lso because it gave the best quality ﬁt in terms of ﬁt error.
The UV–vis detector was calibrated in order to later translate the
rea of the FFF-UV–vis peak into a concentration. The calibration
f the online UV–vis detector was obtained by injecting increasing
mounts of F-AmP peptide in the FFF system without cross ﬂow.
he area under the curve of the UV signals was plotted against the
oncentration of peptide used. The equation obtained from ﬁtting
he data was used to calculate the total concentration of peptide
ound to the liposomes.
.7. Counting liposome concentration by qNano
Measurements were made using the qNano system obtained
rom Izon Science (Christchurch, New Zealand) incorporating the
uid cell, stretching apparatus, data recording, and analysis soft-
are (Version 3.1). Samples were prepared by diluting the stock
iposome dispersion (2.5 mM lipid concentration in phosphate
uffer) in PBS 2x to 1:100. Each sample was run in triplicate. The
ulse signal was  calibrated with a 100 nm polystyrene particle
tandard supplied by Izon Science. The pores used were designated
NP200” by the manufacturer and are described as the most suitable
or detecting particles in the range of 100−300 nm.  The macro-
copic stretch applied to the membrane was 44 mm.  An appropriate
oltage (0.3 V) was selected for all experiments to enable the detec-
ion of the peaks above the level of noise (<10 pA). This was judged
o be adequate when the peak magnitude was greater than 0.12 nA.
 cm H2O of pressure was applied to the top ﬂuid cell using Izon’s
ariable pressure unit to help facilitate the translocation of parti-
les through the elastic pore. Typically, a bandwidth ﬁlter of 1 kHz
as applied during measurements, and modal values from data
istograms were used in all plots. In all experiments, 80 L of elec-
rolyte buffer was placed in the lower ﬂuid cell. The volume in
he upper ﬂuid cell was 40 L. After recording, this solution was
ithdrawn, and the ﬂuid cell and pore were washed by repeatedly
eplacing PBS in the upper ﬂuid cell until no particles were apparent
n the signal trace. To generate error bars in all ﬁgures, the mean
nd standard deviation of three repeat experiments was  used..8. Negative stained transmission electron microscopy
TEM images were taken with a JEOL JEM 2100 TEM microscope
t 200 keV. A 1422 (2015) 260–269
The negative stain used was 1% of uranyl acetate dissolved in
distilled water (pH 4.5). The stain was  ﬁltered through a 0.22 m
ﬁlter that had been pre-rinsed with large volumes of distilled water.
The ﬁltered stain was stored in the dark at 4 ◦C.
Liposome dispersion was  diluted to 0.5 mg  of lipid/mL. One drop
of this dispersion was  placed on a glow discharged 200-mesh for-
mvar copper grid, allowed to adsorb for 3 h at 4 ◦C and the surplus
was removed by ﬁlter paper. The grid was  then placed on top of
the surface of a drop of 1% uranyl acetate for 1 min  and the excess
removed with ﬁlter paper. The grid was  dried in a desiccator at
room temperature and examined the day after.
2.9. Theoretical isoelectric points
The theoretical isoelectric point of AmP  and n-AmP pep-
tides were computed from ExPaSy Bioinformatics Resource Portal
(http://web.expasy.org/compute pi/).
3. Results and discussion
3.1. Liposomes as bacterial and mammalian membrane mimetics
Different liposomes were assembled using 4 different phos-
pholipids: palmitoyloleoylphosphatidylcholine (POPC), palmitoy-
loleoylphosphatidylglycerol (POPG), dilaurylphosphatidylcholine
(DLPC), and dilaurylphosphatidylglycerol (DLPG). The phospho-
lipids carrying the choline terminal head group are neutral (POPC,
DLPC), while those carrying the glycerol head group are negatively
charged (POPG, DLPG). In addition, the dilauryl and palmitoyloleoyl
aliphatic chains differ in length (C12 vs. C18, respectively), result-
ing inmembranes of two thicknesses which, together with a double
bond in the palmitoyloleoyl chain, renders the PO-type membranes
thicker and less ﬂuid [22].
3:1 molar ratios of neutral and negatively charged phos-
pholipids gave Anionic Unilamellar Vesicles (AUVs). Zwitterionic
Unilamellar Vesicles (ZUVs) were assembled from the neutral
lipids only. The total of four liposomes provided model systems
mimicking the negatively and neutrally charged membrane lipids,
respectively [17].
3.2. Size distribution of liposomes by DLS
The size and polydispersivity of the four different liposomes
were measured by DLS. The Z-average particle diameter of PO-
and DL-AUVs, PO- and DL-ZUVs was  124, 108, 156 and 107 nm
respectively. The polydispersivity represented by the PdI value
was less than 0.15 for all samples analyzed, thus conﬁrming the
homogeneity of the different liposomes after extrusion. These
values are comparable with the ones found in literature, where
large unilamellar vesicles, prepared by extruding lipid dispersion
trough polycarbonate ﬁlters of 100 nm,  have a size of 120–140 nm
[23]. The DLS data indicates that liposomes formed by lauryl alkyl
chains have slightly smaller size than liposomes containing the
palmitoyl chain. These results are consistent with the shorter C12
chain present in the DL-type samples compared to the C18 chain
present in the PO-type ones. The Z-potential was  measured in phos-
phate buffer at pH 7.4 as −70.3 ± 11.5, −64.9 ± 11.7, −10.1 ± 6.9,
−12.5 ± 7.4 mV  for PO- and DL-AUVs, PO- and DL-ZUVs respec-
tively. These data conﬁrm that AUVs and ZUVs have negative and
neutral electric potential respectively.
3.3. Size distribution of liposomes by AF4-DLS systemDynamic light scattering cannot provide an adequate measure of
polydispersed samples, containing mixtures of nanoparticles which
have less than a factor of 3 size difference [24]. To overcome some
P. Iavicoli et al. / J. Chromatogr. A 1422 (2015) 260–269 263
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pig. 1. AF4-MALS-DLS analysis of PO-AUVs. (A) Fractogram showing the light 90◦ s
cale,  logarithmic scale) calculated from AF4-MALS data using the coated sphere ﬁt
eporting the DLS Z-average values. (B) Cross ﬂow method used for the AF4 separat
f these drawbacks, we analyzed the liposomes with AF4 coupled
nline with MALS, DLS and UV detectors (AF4-MALS-DLS-UV). A
epresentative example of AF4-MALS-DLS analysis for PO-AUVs is
hown in Fig. 1A. The fractogram (90◦ light scattering detector)
hows the presence of a broad peak centered at 42 min  exit time
hich suggests the presence of particles of a deﬁnite size range.
he online MALS and DLS detectors allow the direct measurement
f both the gyration diameter [25] (continuous line in Fig. 1A) and
he hydrodynamic diameter (dotted line in Fig. 1A) of the liposomes
xiting the AF4 separation channel.
The fractogram and the monotonic increase of the particle size
ith the exit time (Fig. 1A) indicate that the cross ﬂow solvent
phosphate buffer 10 mM,  pH 7.4) and the cross ﬂow method used
starting at 1 mL/min and decreasing to 0.1 mL/min with a power
radient, Fig. 1B) was optimal to achieve a satisfactory separation of
he polydispersed PO-AUVs. This method provides an ideal compro-
ise between achieving good separation over a wide range of sizes,
hile keeping the overall experiment time reasonable. In order
o evaluate the adsorption of the liposomes to the accumulation
all during size separation, the total amount of particles eluting
rom the channel with and without cross-ﬂow was  calculated
omparing the area under the curve (AUC) of the UV signals. It
as found that the AUC was the same with and without separa-
ion. This indicates that the AF4 separation method used in this
tudy did not cause any liposome retention inside the channel.
he AF4-DLS data for PO-AUVs thus shows the presence of lipo-
omes with sizes comprised between 90 and 150 nm,  with a peak
t 123 nm.  Similar measurements gave hydrodynamic diameters
t the peak maximum of 110, 151, 104 nm for DL-AUVs, PO- and
L-ZUVs, respectively in excellent agreement with the Z-average
alues obtained by DLS in batch mode.
.4. Shape factor of liposomes by AF4-MALS-DLS system
The availability of the online MALS and DLS data allows deter-
ining the morphology of the particles by calculating the shapeactor (given by the RG/RH ratio,  [26]). The use of the shape
actor for shape determination has been reported for both macro-
olecules [27–29] and nanoparticles [30–33]. To determine the
article size and shape of the liposomes, different ﬁtting methodsing detector signal (right hand scale), gyration diameter (continuous line, left hand
ethod and hydrodynamic diameter (dotted line, left hand scale, logarithmic scale)
for light scattering data retrieved from MALS were evaluated. The
comparison between the different ﬁtting models showed that the
coated sphere model gave the best ﬁtting results and was  more
suitable to describe our data than any other geometry. The RG/RH
ratios were calculated for PO-AUVs between 35 and 47 min. The
shape factor was found to be quite constant along the particle size
distribution (Fig. A-1). Rigid spheres nanoparticles (where the mass
has an homogenously distribution) have predicted shape factor val-
ues of 0.775, coated spheres (where the mass is concentrated on a
thin layer on the external surface) have  values close to 1, while
oblong nanoparticles (such as nanorods, nanotubes or nanoﬁbers)
would have  values larger than 1 [34]. Thus, our results with  val-
ues close to 1, show that PO-AUVs have the morphology of a coated
sphere and a size distribution comprised between 90 and 150 nm;
furthermore, their shape is kept constant and unaltered during the
AF4 separation. These results are consistent with previous obser-
vations that the coated sphere model is the best ﬁtting method for
liposomes [19,35].
Similarly, at the maximum of the AF4-LS 90◦ peak, the  values
for PO- and DL-AUVs are 1.04 and 0.95 respectively. This indicates
that the liposomes under study have coated sphere morphology
and do not change their spherical shape during the duration of the
whole analysis.
3.5. Characterization of liposome–peptide complexes
3.5.1. Size distribution by DLS
Once optimized, the methods were used to characterize the size
distribution and morphology of our cell membrane mimics inter-
acting with a de novo designed archetypal antimicrobial peptide.
For the purpose of the study two synthetic peptides were inves-
tigated – a positively charged antimicrobial peptide (AmP) and
its anionic,“mirror”, non-antimicrobial counterpart (nAmP). AmP
interacts with the negatively charged bacterial membrane, while
the nAmP does not.
The peptides (whose exact sequence will be reported elsewhere)
were assembled according to the previously published princi-
ples [36,37]. More speciﬁcally, the 21 amino acids polypeptide
has a generic sequence – PNPHNPHPNPHNPHPNPHNPH – where
P – polar; N – neutral, polar or small; H – hydrophobic. When
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Table 1
Size measurement by DLS in batch mode of PO-AUVs, ZUVs and DL-AUVs, ZUVs after addition of either the peptide AmP or the peptide nAmP at variable L/P mole ratios. The
size  is the Z-average of the hydrodynamic diameter and it is expressed in nm.  The PDI of all measurements is less than 0.15.
Liposome alone 100:1 80:1 60:1 40:1 20:1
PO-AUV/AmP 124.2 ± 1.1 122.6 ± 0.9 121.8 ± 0.3 120.5 ± 1.2 Increased Scattering Increased Scattering
PO-AUV/nAmP 124.2 ± 1.1 124.1 ± 0.3 123.3 ± 0.6 124.1 ± 1.9 123.5 ± 1.2 122.7 ± 0.8
PO-ZUV/AmP 156.1 ± 1.1 153.8 ± 0.8 155.5 ± 0.6 152.4 ± 1.4 153.6 ± 1.6 154.5 ± 1.3
DL-AUV/AmP 108.1 ± 0.1 134.4 ± 2.4 135.2 ± 1.7 137.2 ± 1.5 148.6 ± 0.9 Increased Scattering
DL-AUV/nAmP 108.1 ± 0.1 110.6 ± 1.1 114.1 ± 1.5 111.4 ± 1.3 112.3 ± 1.8 111.7 ± 0.7
DL-ZUV/AmP 106.7 ± 0.9 107.2 ± 1.1 107.5 ± 0.7 105.8 ± 1.1 106.2 ± 0.4 107.2 ± 0.8
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tig. 2. Separation by AF4 and analysis by 90◦-LS and ﬂuorescence detectors (500 nm
ole  ratios. (C and D) PO-AUVs mixed with F-nAmP at variable L/P mole ratios. The
he “P” amino acids are positively charged the resulting molecule
AmP, molecular weight 2535 Da) has an isoelectric point of 12.3.
pon binding to negatively charged phospholipid bilayers the AmP
eptide forms an amphipathic helix, with polar and hydrophobic
esidues segregating into polar and hydrophobic faces. In the case
f “P” being negatively charged, the molecule (nAmP, molecular
eight 2371 Da) has an isoelectric point of 3.5. Thus, while hav-
ng identical hydrophobic faces, AmP  and nAmP have oppositely
harged (cationic and anionic) polar faces.The peptides also accommodate speciﬁc experimental require-
ents such as the presence of a single tyrosine (Y) residue to
acilitate accurate concentration determination by UV. The adop-
ion of the peptide -helical structure was conﬁrmed by circulartation and 522 nm emission). (A and B) PO-AUVs mixed with F-AmP at variable L/P
ntration of liposomes is ﬁxed.
dichroism experiments after mixing AmP  with both PO-  and DL-
AUVs (data not shown).
In order to follow the change in the hydrodynamic diameter
of each liposome upon addition of increasing amounts of both
polypeptides we  used DLS in batch mode. This change was used as
an indicator of the afﬁnity and penetration of the peptide with the
membrane. Table 1 compares the size of bare liposomes with the
size of the complex formed after addition of peptides at different
lipids to peptide (L/P) mole ratios.This simple experiment allowed identifying the point at which
further addition of peptide disrupted the stability of the lipo-
somes. That point was reached at L/P mole ratio of 40:1 for
PO-AUVs/AmP and at L/P mole ratio of 20:1 for DL-AUVs/AmP when
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he liposomes collapsed as judged by larger sizes and broader size
istributions.
As measured by DLS, liposomes alone are stable up to 1 month
f stored protected from light at 4 ◦C. As regarding the lipo-
ome/peptide complexes, PO-AUV/AmP are stable up to L/P mole
atio 60:1, whereas DL-AUV/AmP are stable up to L/P mole ratio
00:1. Lower ratios of these complexes show aggregation by DLS
fter 24 h.
The DLS data shows that for almost all samples, there is no signif-
cant change in size (as measured by batch mode DLS) upon addition
f AmP and nAmP peptides to the different liposomes. The only
igniﬁcant change in the hydrodynamic diameter of the complex is
etected in the case of DL-AUVs/AmP system that shows an increase
rom around 110 nm for the free liposome to around 140 nm for the
omplexes.
The formation of a layer of peptides around the liposomes would
ncrease minimally the diameter of the liposome–peptide complex
nd thus could not be detected by DLS in batch mode.
.5.2. Peptide binding speciﬁcity by AF4-MALS-Fluorimeter
ystem
To better characterize peptide–liposome interactions, we  cou-
led the AF4 separation unit with online ﬂuorescence detector in
rder to obtain a peptide-speciﬁc signal. Fluorescence of a tyrosinetation and 522 nm emission). (A and B) DL-AUVs mixed with F-AmP at variable L/P
ntration of liposomes is ﬁxed.
residues present in each peptide was  not sufﬁcient to detect
peptides at such used concentrations, therefore the carboxyﬂuo-
rescein (F) was attached to the N-terminus of each peptide via a
beta-alanine spacer, termed F-AmP and F-nAmP, allowing detec-
tion by ﬂuorometer and UV detectors.
All four membrane models alone and mixed with cationic and
anionic peptides at different L/P ratios were analyzed using the
AF4-MALS-Fluorimeter-UV system. The concentration of liposomes
was kept constant at 1.2 mM.  Fig. 2 shows the AF4 analysis (90◦
light scattering and ﬂuorescence detectors) of the PO-AUVs mixed
with increasing concentrations of F-AmP (Fig. 2A and B) and F-
nAmP peptides (Fig. 2C and D). The fractograms obtained with the
scattering detectors (Fig. 3A and C) show only one broad peak cen-
tered at 42 min  exit time, which is attributed to the liposomes.
The retention time and the intensity of the peaks for all samples
are quite similar to each other, showing no signiﬁcant change in
dimensions and concentrations upon addition of peptide to the
liposomes.
The ﬂuorescence detector clearly shows the binding of F-AmP
to the PO-AUVs (Fig. 2B). The data indicates that the maximum ﬂu-
orescence is reached for particles at exit time of around 40 min  and
that the integral of the ﬂuorescence signal increases linearly with
an increasing amount of ﬂuorescent peptide. By contrast, F-nAmP
peptide does not cause any increase in ﬂuorescence (Fig. 2D), while
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Table 2
Quantiﬁcation of the concentration of F-AmP peptide bound to the liposomes. Per-
centage of peptide bound to liposomes PO-AUVs amd  DL-AUVs at variable L/P mole
ratios.
600:1 300:1 100:1 80:1
PO-AUV/F-AmP 95.0 ± 1.6 64.3 ± 5.8 54.9 ± 4.0 49.0 ± 2.766 P. Iavicoli et al. / J. Chrom
one F-AmP and F-nAmP is able to bind to the neutrally charged
O-ZUVs (data not shown).
These results conﬁrm that F-AmP selectively binds to the nega-
ively charged PO-AUVs, while the negatively charged F-nAmP does
ot interact with either negative or neutral liposomes.
The experimental data suggest a model for the peptide-liposome
omplex AmP-AUV: the peptide interacts with the liposomes by
lectrostatic interactions. Upon binding, the peptide folds into an
mphipathic -helix with a polar and a hydrophobic face, which
avors the interaction with the hydrophobic part of the phospho-
ipid molecules.
Similar results could be expected when repeating the experi-
ents with both the DL-AUVs and ZUVs, even if the addition of
-AmP to the negative liposome causes an increase in size of the
esulting complex (Table 1). Quite surprisingly, Fig. 3A shows that
he addition of F-AmP to DL-AUVs results in the formation of a
econd peak in the FFF-LS fractogram compared to the liposomes
lone.
The data indicates that the addition of F-AmP to DL-AUVs causes
he formation of two well-deﬁned liposome/F-AMP complexes: the
rst one with the same size of a free DL-AUVs and the second one
ith a larger size. With the increasing amount of F-AmP, the pop-
lation of the smaller complex decreases, while the population of
he bigger one increases. In addition, the ﬂuorescence data (Fig. 3B)
hows that the F-AmP peptide indeed binds to both small and large
articles. By contrast, the addition of F-nAmP to DL-AUVs does not
ause the appearance of a second peak in the FFF-LS fractogram
Fig. 3C) and the ﬂuorescence data (Fig. 3D) shows that the peptide
oes not bind, as expected, to the liposomes. Similarly, no signal
hange was observed for the DL-ZUVs/F-AmP complexes (data not
hown).
.5.3. Size distribution by AF4-UV-DLS system
To measure the size of the two complexes in the DL-AUVs/F-
mP system, the hydrodynamic diameter was recorded by DLS
n-line after the AF4 separation step. Fig. 4 shows the AF4-UV–vis
ractogram obtained by recording at 500 nm (the absorbance max-
ma  of the ﬂuorescent-labeled F-AmP peptide) and the particle
iameter (obtained by online DLS) for the free DL-AUVs (red line
nd dots) and the complex at L/P ratio 40. The data indicate that
he smaller DL-AUVs/F-AmP complex does not change the size of
round 110 nm compared to free liposomes and that the bigger
omplex has a size of around 180 nm.  Similar experiments using
ig. 4. Separation by AF4 and size measurement by DLS online of liposomes DL-
UVs alone and mixed with the F-AmP peptide at L/P mole ratio 40. Fractograms
howing the UV detector signal (left hand scale), hydrodynamic diameter (dotted
ine, right hand scale, logarithmic scale) reporting the DLS Z-average values.DL-AUV/F-AmP 106.8 ± 15.4 86.7 ± 8.6 66.9 ± 4.0 64.1 ± 3.7
AF4-DLS for the complexes PO-AUVs/F-AmP show no measurable
size increase compared to liposomes alone (data not shown).
Thus, the increase in size measured by DLS in batch mode
(Table 1) for DL-AUVs/F-AmP complexes is in reality caused by the
presence of an additional population of larger complexes. These
results highlight the well-known difﬁculty of DLS measurements in
resolving particles which have less than a factor of 3 size difference
and the fact that the intensity of the scattered light is inversely pro-
portional to sixth power of the radius of the nanoparticle [38–40].
All these considerations highlight the importance of verifying the
“real” size of particles present in the sample by a method that
separates particles based on their size, like the AF4 system used
herein.
The data of Fig. 4A and B allow estimating the relative number
of peptides bound to the two  DL-AUVs/F-AmP complexes. In fact, at
L/P ratio of 80, the integrals of the light scattering peaks of complex
1 (size 110 nm)  and complex 2 (size 180 nm)  are equal; Considering
that the intensity of the scattered light scales as R6 it can be con-
cluded that complex 1 contains 32 times the number of particles of
complex 2. On the other hand, the integrals of ﬂuorescence peaks
for complex 1 and complex 2 are in a 60 to 40 ratio. Thus, each
particle of complex 2 binds approximately 20 times more peptides
than complex 1, while based on total surface area considerations
it should bind only 4 times more peptides. This phenomenon was
not observed for thicker and less ﬂuid PO-AUVs that formed a single
main peak upon peptide interaction [41].
3.5.4. Quantiﬁcation of peptides bound to liposomes by AF4-UV
system
The use of the ﬂuorescently labeled peptides allowed quanti-
fying the amount of peptides bound to liposomes by either using
the UV–vis or ﬂuorescence detectors. We have noticed that while
the ﬂuorescence detector is around 10 times more sensitive, the
UV–vis data are more reproducible and the response vs. concentra-
tion of labeled peptide is more linear than ﬂuorescence data, thus
we have used the UV–vis data for quantiﬁcation. By plotting the
different concentrations of F-AmP used in the mixtures with both
AUVs models against the AUC of the UV signals, it could be observed
that the intensity of UV signals increased linearly with the peptide
concentration (Fig. A-2).
In order to later translate the area of the FFF-UV–vis peak into
a concentration, the calibration of the UV detector was performed
and the resulting equation used to calculate the percentage of the
bound peptide with respect to the total amount of peptide used at
different L/P ratios for both PO-AUVs/F-AmP and DL-AUVs/F-AmP
complexes (Table 2).
By plotting the percentage of peptide bound to liposomes
towards the L/P mole ratios (Fig. 5), it could be observed that,
for both liposome models, the percentage of bound peptide with
respect to the total amount added decreases by increasing the total
amount of peptide. The data seems to reach a plateau at around 60%
of bound peptide for L/P ratio 80. Reporting the data as bound pep-
tides per liposome versus free peptide per liposome and ﬁtting to
a Hill-type equation (Fig. A-3) gives a maximum number of bound
peptides of 12000 and suggest a non-cooperative binding behavior
(see supporting information for details).
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At ratios lower than 60, precipitation started to occur, which can
e attributed to liposome clustering.
In order to estimate the number of F-AmP peptide bound to
ach PO-AUVs, the liposome concentration was measured by using
Nano Tunable Resistive Pulse Sensor [42–45]. The number of lipo-
omes (1.80 ± 0.3 E+10) was divided by the total number of peptides
ound to the liposomes. It was found that the number of peptides
ound to each liposome increases from around 3000 at L/P ratio
00 to around 11000 peptides at L/P ratio 80.
Considering a surface area of 45,216 nm2 for the 120 nm diam-
ter liposome and the area occupied by the peptide in either
 parallel (39,000 nm2) or a perpendicular (16,000 nm2) orienta-
ion with respect to the liposome, the percentage of occupied
rea by the peptides on each liposome would be more than 40%.
hese considerations suggest that the action of AMP  could be due to
oth membrane disruption and to blocking of membrane function,
r a combination of the two.
.5.5. Shape factor by AF4-MALS-DLS system
Finally, the gyration diameter of the complexes was measured
y AF4-MALS and the results compared with the ones coming from
he AF4-DLS, thus allowing us to calculate the resulting shape fac-
ors (Table 3).
In order to have information regarding the particle shape [33],
e calculated the shape factor  = RG/RH for all liposome com-
lexes at the peak maximum of the LS 90◦ signal. From the data
able 3
eometric diameter (dG) calculated from AF4-MALS data using the coated sphere ﬁtting
lone  and mixed with F-AmP peptide. The shape factor  is given by RG/RH.
Liposome alone 600:1 
PO-AUV/F-AmP 131.0 ± 0.2 (dG)
125.6 (dH)
 = 1.04
127.8 ± 0.1 (dG)
125.2 (dH)
 = 1.02
DL-AUV/F-AmP 108.4 ± 0.1 (dG)
114.1 (dH)
 = 0.95
107.6 ± 0.1 (dG)
112.6 (dH)
 = 0.96AUVs and DL-AUVs. Plot of the percentage of peptide bound to liposomes towards
in Table 3 we can conclude that all samples have a shape fac-
tor close to 1, which is typical of coated sphere morphology. This
provides indications that the binding of the peptide to the lipo-
somes does not disturb the original morphology of the liposomes.
However a change towards shape factors smaller than unit was
noticed for the larger complex in the DL-AUVs/F-AmP system at
both 100:1 and 80:1 ratios. This shows that the morphology of the
liposome-peptide complex keeps a spherical shape, and the slightly
reduced shape factor for the biggest DL-AUVs/F-AmP indicates a
more homogeneous mass distribution, suggesting the formation of
multilamellar liposomes. Cationic peptides can bridge like-charged
membranes and, as a consequence, favor the conversion into a
multilamellar phase [46]. In order to conﬁrm the formation of mul-
tilamellar vesicles, dispersion of DL-AUVs alone and mixed with
F-AmP at 80:1 were analyzed by negative staining Transmission
Electron Microscopy for enhanced detail and morphological inves-
tigations. Fig. A-4 A and B shows negative stained DL-AUVs of a
wide size distribution ranging from 80 nm to 200 nm.  The majority
of these appear as unilamellar vesicles. In the presence of AmP  at
80:1 L:P ratio (A-4C and D) multilamellar structures were apparent,
while the shape of some liposomes appeared distorted. This effect
might be due to both the high vacuum conditions needed to operate
the electron microscope and the osmotic shock of liposomes dur-
ing the staining process (interaction between the sample and the
uranyl acetate in water solution). Although this technique seems
still not well optimized for studying the real size and morphology
 mode and hydrodynamic diameter (dH) determined from AF4-DLS of liposomes
300:1 100:1 80:1
129.8 ± 0.2 (dG)
125.4 (dH)
 = 1.03
127.2 ± 0.2 (dG)
120.1 (dH)
 = 1.06
123.8 ± 0.1 (dG)
121.6 (dH)
 = 1.02
106.2 ± 0.1 (dG)
110.7 (dH)
 = 0.96
102.2 ± 0.2,
157.4 ± 0.2 (dG)
112.4, 191.0
(dH)
  = 0.91, 0.82
104.4 ± 0.2,
176.4 ± 0.3 (dG)
113.0, 202.3
(dH)
 = 0.92, 0.87
2 atogr.
o
l
4
d
a
–
m
c
i
s
t
p
i
t
m
m
s
l
i
p
o
d
w
t
e
f
a
a
m
a
A
F
2
A
t
0
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[68 P. Iavicoli et al. / J. Chrom
f liposomes, it is good enough to conﬁrm the presence of multi-
amellar liposomes.
. Conclusions
The AF4 multidetection system used in this study enabled the
etermination of accurate particle size distribution and provided
n unprecedented level of characterization for studying liposome
 peptide interactions. The use of online DLS and MALS measure-
ents allowed to both measure the unbiased size of particles after
ontinuous and non-destructive particle separation and to gain
nformation on their shape and morphology by detecting their
hape factor. Using this information it was possible to identify sub-
le differences in complexes between positively charged F-AmP
eptide with both the negatively charged PO- and DL-AUVs. While
n the ﬁrst case, the complex was composed of a single popula-
ion with a similar size as the PO-AUVs alone and coated sphere
orphology, in the latter we identiﬁed, in addition to the “nor-
al” complex, a second complex with a larger size and a perturbed
pherical morphology. This unprecedented level of insights high-
ights the potential of the techniques that we have developed and
s a clear reminder of the intrinsic weaknesses of measuring size of
opydispersed samples using DLS in batch mode. Furthermore, the
nline coupling of the UV and ﬂuorescence detectors enables one to
irectly quantify the amount of bound peptides to each liposome.
The application of this method to study other liposome systems
ould be quite straightforward, and it is reasonable to assume that
his method will be very useful in studying liposome–peptide (and
ven proteins) interaction in the search for therapeutic peptides. In
act, liposomes are of particular interest because of their potential
s drug delivery system, but attention has to be given to their sep-
ration as they are porous and pressure-sensitive. The described
ethodhas clear advantages in this regard as it does not break,
gglomerate, or alter liposomes while eluting.
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